# FDA cleared 7.2 mg Wegovy; 20.7% mean weight loss in trial - Date: 2026-04-07 - Category: Biotech & Life Sciences In the STEP UP trial, 22% of patients on Wegovy HD reported dysesthesia versus 6% on the standard dose. Novo Nordisk is not leading with that number. ---